JPH08509487A - シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体 - Google Patents

シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体

Info

Publication number
JPH08509487A
JPH08509487A JP6524018A JP52401894A JPH08509487A JP H08509487 A JPH08509487 A JP H08509487A JP 6524018 A JP6524018 A JP 6524018A JP 52401894 A JP52401894 A JP 52401894A JP H08509487 A JPH08509487 A JP H08509487A
Authority
JP
Japan
Prior art keywords
biphenylyl
formula
methyl
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6524018A
Other languages
English (en)
Japanese (ja)
Inventor
ホッジソン、サイモン・ティーンバイ
ウエイツ、ピーター・ジョン
Original Assignee
ザ・ウエルカム・ファウンデーション・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・ウエルカム・ファウンデーション・リミテッド filed Critical ザ・ウエルカム・ファウンデーション・リミテッド
Publication of JPH08509487A publication Critical patent/JPH08509487A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP6524018A 1993-04-27 1994-04-26 シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体 Pending JPH08509487A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939308652A GB9308652D0 (en) 1993-04-27 1993-04-27 Anti-inflammatory compounds
GB9308652-8 1993-04-27
PCT/GB1994/000885 WO1994025430A1 (fr) 1993-04-27 1994-04-26 Derives de l'acide hydroxamique inhibiteurs de la cyclooxygenase et de la 5-lipoxygenase

Publications (1)

Publication Number Publication Date
JPH08509487A true JPH08509487A (ja) 1996-10-08

Family

ID=10734525

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6524018A Pending JPH08509487A (ja) 1993-04-27 1994-04-26 シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体

Country Status (6)

Country Link
EP (1) EP0696271A1 (fr)
JP (1) JPH08509487A (fr)
AU (1) AU6574994A (fr)
GB (1) GB9308652D0 (fr)
WO (1) WO1994025430A1 (fr)
ZA (1) ZA942911B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807626A4 (fr) * 1995-02-02 1998-05-06 Nikken Chemicals Co Ltd Derives de n-hydroxyuree
JPH11507670A (ja) * 1995-06-12 1999-07-06 ジー．ディー．サール アンド カンパニー シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療
WO2005061448A1 (fr) * 2003-12-24 2005-07-07 Monash University Compositions et methodes de traitement d'affections vasculaires
CN103450077B (zh) 2007-06-08 2016-07-06 满康德股份有限公司 IRE-1α抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK117986A (da) * 1985-03-16 1986-09-17 Wellcome Found Arylderivater, fremgangsmaader til deres fremstilling og deres anvendelse
PL154186B1 (en) * 1987-07-15 1991-07-31 Wellcome Found Method for manufacturing arylic derivatives of the hydroxamic acid
FI900536A0 (fi) * 1989-02-03 1990-02-02 Wellcome Found Anti-inflammatoriska arylkompositioner.
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
US5169854A (en) * 1992-02-26 1992-12-08 Abbott Laboratories N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity

Also Published As

Publication number Publication date
ZA942911B (en) 1995-10-26
EP0696271A1 (fr) 1996-02-14
GB9308652D0 (en) 1993-06-09
AU6574994A (en) 1994-11-21
WO1994025430A1 (fr) 1994-11-10

Similar Documents

Publication Publication Date Title
CN101309912B (zh) 噁唑化合物和药物组合物
TWI574941B (zh) 抗菌劑
US5602277A (en) Substituted benzene derivatives useful as neuraminidase inhibitors
JP3894949B2 (ja) 抗アテローム性動脈硬化症ジアリール化合物
TW200304910A (en) Acetylene derivatives having MGluR5 antagonistic activity
EP0669311A1 (fr) Benzamides
JPH10182583A (ja) 新規ヒドロキサム酸誘導体
EP0687249A1 (fr) Balanoides
PL154186B1 (en) Method for manufacturing arylic derivatives of the hydroxamic acid
DE4327365A1 (de) Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung
EP0652864A1 (fr) Derives d'acide hydroxamique et leur utilisation a titre de composes anti-inflammatoires
JP2004529085A (ja) 免疫性疾患を治療するための新規な１，２−ジフェニルエテン誘導体
JP2001518115A (ja) 新規なピリジン誘導体およびそれを含有する医薬組成物
EP0558563B1 (fr) Composes anti-inflammatoires
EP0623023A1 (fr) Analogues retroverses d'agents anticancereux a oligopeptides de pyrrole-amidino, leur procede de preparation, et compositions pharmaceutiques contenant ces analogues
EP1439164B1 (fr) Nouveaux composes de phenylethanolamine ayant une fonction d'excitation d'un beta2-accepteur et leur procede de preparation
AP454A (en) Therapeutic compounds with hydroxamic acid derivatives.
JPH08509487A (ja) シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体
US4607048A (en) 7-oxabicycloheptane substituted aryl amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction
JPH08502046A (ja) 心臓血管系疾患に用いられるベンゼンアルカン酸
US5006555A (en) Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors
EA010133B1 (ru) Производные формамида, пригодные в качестве адренорецептора
JPH07258259A (ja) シクロオクタジエン誘導体
JPH059168A (ja) メタンスルホンアミド化合物
MXPA01002563A (en) Benzene derivatives and medicinal use thereof